MedPath

STUDY OF EFFECT IN RESIDUAL GASTRIC VOLUME WITH TWO DIFFERENT DOSES OF DEXLANSOPRAZOLE IN DIABETIC PATIENTS POSTED FOR ELECTIVE SURGERIES

Phase 2
Conditions
Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
Registration Number
CTRI/2024/02/062392
Lead Sponsor
SHRI BM PATIL MEDICAL COLLEGE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

PATIENTS AGE BETWEEN 18 - 80 YEARS

DIABETIC PATIENTS ADMITTED FOR ELECTIVE SURGERY WITH ASA GRADE 2 & 3

Exclusion Criteria

PATIENT HISTORY OF GASTRIC SURGERIES

PREGNANT WOMEN

PATIENT UNABLE TO TO POSITION IN RIGHT LATERAL DECUBITUS

HISTORY OF ALLERGY TO DRUGS

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MEASUREMENT OF FASTING GASTRIC RESIDUAL VOLUME IN TWO DIFFERENT DOSES OF DEXLANSOPRAZOLE 30 Mg & 60MgTimepoint: 2 hours prior to surgery <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
TO ASSESS THE POST OPERATIVE NAUSEA AND VOMITING WITHIN 24 HOURS.Timepoint: 24 HOURS
© Copyright 2025. All Rights Reserved by MedPath